Effects of adiponectin deficiency on structural and metabolic remodeling in mice subjected to pressure overload

Abstract

Recent data suggest adiponectin, an adipocyte-derived hormone, affects development of heart failure in response to hypertension. Severe short-term pressure overload [1-3 wk of transverse aortic constriction (TAC)] in adiponectin(-/-) mice causes greater left ventricle (LV) hypertrophy than in wild-type (WT) mice, but conflicting results are reported regarding LV remodeling, with either increased or decreased LV end diastolic volume compared with WT mice. Here we assessed the effects of prolonged TAC on LV hypertrophy and remodeling. WT and adiponectin(-/-) mice were subjected to TAC and maintained for 6 wk. Regardless of strain, TAC induced similar LV hypertrophy ( approximately 70%) and upregulation of mRNA for heart failure marker genes. However, LV chamber size was dramatically different, with classic LV dilation in WT TAC mice but concentric LV hypertrophy in adiponectin(-/-) mice. LV end diastolic and systolic volumes were lower and ejection fraction higher in adiponectin(-/-) TAC mice compared with WT, indicating that adiponectin deletion prevented LV remodeling and deterioration in systolic function. The activities of marker enzymes of mitochondrial oxidative capacity were reduced in WT TAC mice by approximately 35%, whereas enzyme activities were maintained at sham levels in adiponectin(-/-) TAC mice. In conclusion, in WT mice, long-term pressure overload caused dilated LV hypertrophy accompanied by decreased activity of mitochondrial oxidative enzymes. Although adiponectin deletion did not affect LV hypertrophy, it prevented LV chamber remodeling and preserved mitochondrial oxidative capacity, suggesting that adiponectin plays a permissive role in mediating changes in cardiac structure and metabolism in response to pressure overload.

Fig. 1.

Left ventricular (LV) mass/tibia length (A), the mRNA expression atrial natriuretic peptide (ANP, B) and the ratio of the mRNA expression of myosin heavy chain-β to -α (C) expressed as a fraction of the sham wild-type (WT) group. TAC, transverse aortic constriction. Values are means ± SE; n = 12–15 mice/group. *P < 0.05 vs. sham.

Fig. 2.

Echocardiographic assessment of end diastolic volume (A), end systolic volume (B), LV mass to end diastolic volume (EDV) ratio (C), and ejection fraction (D) 6 wk postsurgery. Values are means ± SE; n = 12–15 mice/group. P < 0.05 vs. sham (*) and vs. wild type (#).

Fig. 3.

Cardiac citrate synthase activity (A) and medium chain acyl CoA dehydrogenase (MCAD) activity (B). Values are means ± SE; n = 12–15 mice/group. P < 0.05 vs. sham (*) and vs. wild type (#).